Indivior Pharmaceuticals Inc (INDV)
$34.16-3.56%Close
SELLRECOVERY · day 20
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $4.3B
- Beta
- 1.11
- P/E (TTM)
- 12.03
- Short % float
- 9.29%
- Days to cover
- 5.3
- SI change
- -6.8%
- 1W
- -5.45%
- 1M
- -0.18%
- vs SPY 1W
- -4.47%
- vs SPY 1M
- -2.04%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 38
- VALUE
- 27
- GROWTH
- 61
- GARP
- 43
- TYPE
- Value / Recovery
Composite of Value · Growth · GARP
ROIC-129.7%
REV YoY-
ROE-216.1%
EPS YoY-
ROA28.8%
GROSS84
OP39
NET27
[VALUATION]
P/E TTM12.03
P/E FWD8.37
SECTOR PE20.48
INDUSTRY PE19.11
P/B-20.59
P/FCF-
EV/EBITDA10.41
EV/EBIT-
PEG1.55
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO0.84
ND/EBITDA-
BETA1.11
Company news
FAQ
- What is LOPJLB’s current signal on INDV?
- LOPJLB’s latest quantitative signal on Indivior Pharmaceuticals Inc (INDV) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is INDV in?
- Indivior Pharmaceuticals Inc (INDV) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Indivior Pharmaceuticals Inc (INDV) do?
- Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the Unite…